New Medicine - A Comprehensive Information and Consulting Service  
HOME PRODUCTS & SERVICES ORDER/INQUIRY PRESS RELEASES EMPLOYMENT CONTACT US

Future Oncology - Technology, Products, Markets, and Service Opportunities

* Requires Adobe Acrobat Reader

FUTURE ONCOLOGY - TECHNOLOGY, PRODUCTS, MARKETS, AND SERVICE OPPORTUNITIES IN THE CANCER FIELD

FUTURE ONCOLOGY
Volume 7 #4/5 April 15, 2003


Anticancer Drugs and Markets

ANTIBIOTIC AGENTS FROM ANTIBIOTIC SOURCES
PART II - NOVEL AGENTS IN DEVELOPMENT

NOVEL ANTICANCER ANTIBIOTICS
  • Actinonin Analogs
  • Anthracyclines
    • GPX-100 and GPX-150
    • MEN 10755
    • PNU-159548
    • WP631
    • WP744
    • WP760
    • WP900
  • Celeptium
  • Distamycin A
    • Brostallicin
  • Duocarmycin
    • CC-1065 analogs
    • KW-2189
  • Elsamitrucin
  • Enediynes
    • C-1027
    • Calichaemicin
    • Lidamycin
    • Neocarzinostatin
  • FK317
  • Geldanamycin/Ansamycin and Analogs
    • 17-(allylamino)-17-demethoxygeldanamycin (17-AAG)
    • 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (17-DMAG;NSC-707545)
    • CNF-101 and analogs
  • Indolcarbazole Antibiotics
    • AT2433-A1, AT2433-A2, AT-2433-B1, and AT2433-B2
    • CEP-701
    • DEAE rebeccamycin (XL 119)
    • J-107088
    • PKC412
    • UCN-01
  • Mithramycin Analogs
  • Prodigiosins
  • Rapamycin/Sirolimus
    • AP23573, AP23675 and AP23841
    • CC-779
    • RAD001
  • Resveratrol
  • Salinospora
  • Spicamycin
    • KRN 5500
  • Taurolidine
TARGETED CYTOTOXIC ANTIBIOTICS
  • Biotinylated CBI-bearing CC-1065 Analogs
  • Bispecific MAb
  • CMC-544
  • Cytotoxic Peptide Conjugates Targeted to their Receptors on Tumors
    • AN-152 and AN-207
    • AN-215
    • AN-238
    • C-terminal gastrin heptapeptide-targeted cytotoxics
  • Danavat-2
  • HPMA-HA-DOX
  • Immunoliposomes
    • Anti-HER2/doxorubicin immunoliposomes
    • EGFr-targeted/epirubicin immunoliposomes
    • MCC-465
  • SGN-15
  • Vitamin-mediated Targeted Delivery
PRODRUGS
  • CPI-0004Na
  • CRX-103
  • Epidoxoform
  • L-377202
  • Plasmin-targeted Doxorubicin
NOVEL FORMULATIONS
  • Liposomal/PEG Formulations
    • Liposome-encapsulated Doxorubicin (LED)
  • MTC-DOX
  • P80DOX-NP
  • Resmycin
  • SMANCS
  • SYN 2002
  • Transdrug Doxorubicin

LIST OF EXHIBITS

Exhibit 1 - Novel Antibiotic Cytotoxics in Development


HOME | PRODUCTS & SERVICES | ORDER/INQUIRY | PRESS RELEASES | EMPLOYMENT | CONTACT US

NEW MEDICINE, INC.
PHONE: 949-830-0448   FAX: 949-830-0887